nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.209	0.243	CbGbCtD
Cilostazol—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.209	0.243	CbGbCtD
Cilostazol—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.157	0.183	CbGbCtD
Cilostazol—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.127	0.147	CbGbCtD
Cilostazol—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0963	0.112	CbGbCtD
Cilostazol—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0612	0.0712	CbGbCtD
Cilostazol—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.0356	CcSEcCtD
Cilostazol—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.0304	CcSEcCtD
Cilostazol—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00415	0.0296	CcSEcCtD
Cilostazol—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0258	CcSEcCtD
Cilostazol—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.0243	CcSEcCtD
Cilostazol—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00341	0.0243	CcSEcCtD
Cilostazol—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.0239	CcSEcCtD
Cilostazol—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.0237	CcSEcCtD
Cilostazol—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.0219	CcSEcCtD
Cilostazol—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.0192	CcSEcCtD
Cilostazol—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.0191	CcSEcCtD
Cilostazol—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.0186	CcSEcCtD
Cilostazol—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.0184	CcSEcCtD
Cilostazol—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0181	CcSEcCtD
Cilostazol—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.0175	CcSEcCtD
Cilostazol—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0164	CcSEcCtD
Cilostazol—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.0163	CcSEcCtD
Cilostazol—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0158	CcSEcCtD
Cilostazol—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.0157	CcSEcCtD
Cilostazol—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.0144	CcSEcCtD
Cilostazol—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.0143	CcSEcCtD
Cilostazol—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0141	CcSEcCtD
Cilostazol—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.014	CcSEcCtD
Cilostazol—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.0134	CcSEcCtD
Cilostazol—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.0133	CcSEcCtD
Cilostazol—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.013	CcSEcCtD
Cilostazol—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0129	CcSEcCtD
Cilostazol—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0128	CcSEcCtD
Cilostazol—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0117	CcSEcCtD
Cilostazol—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0115	CcSEcCtD
Cilostazol—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0111	CcSEcCtD
Cilostazol—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.0104	CcSEcCtD
Cilostazol—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00998	CcSEcCtD
Cilostazol—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00969	CcSEcCtD
Cilostazol—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0095	CcSEcCtD
Cilostazol—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00945	CcSEcCtD
Cilostazol—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00939	CcSEcCtD
Cilostazol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00937	CcSEcCtD
Cilostazol—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00937	CcSEcCtD
Cilostazol—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00919	CcSEcCtD
Cilostazol—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00911	CcSEcCtD
Cilostazol—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00909	CcSEcCtD
Cilostazol—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00904	CcSEcCtD
Cilostazol—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00869	CcSEcCtD
Cilostazol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00867	CcSEcCtD
Cilostazol—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00865	CcSEcCtD
Cilostazol—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00861	CcSEcCtD
Cilostazol—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00859	CcSEcCtD
Cilostazol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00807	CcSEcCtD
Cilostazol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00785	CcSEcCtD
Cilostazol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.0078	CcSEcCtD
Cilostazol—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00776	CcSEcCtD
Cilostazol—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00742	CcSEcCtD
Cilostazol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00724	CcSEcCtD
Cilostazol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000979	0.00699	CcSEcCtD
Cilostazol—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000975	0.00696	CcSEcCtD
Cilostazol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000952	0.00679	CcSEcCtD
Cilostazol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000948	0.00677	CcSEcCtD
Cilostazol—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.00674	CcSEcCtD
Cilostazol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000921	0.00657	CcSEcCtD
Cilostazol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.0065	CcSEcCtD
Cilostazol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000898	0.00641	CcSEcCtD
Cilostazol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000898	0.00641	CcSEcCtD
Cilostazol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000898	0.00641	CcSEcCtD
Cilostazol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000895	0.00639	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000892	0.00637	CcSEcCtD
Cilostazol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000888	0.00633	CcSEcCtD
Cilostazol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000861	0.00615	CcSEcCtD
Cilostazol—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000856	0.00611	CcSEcCtD
Cilostazol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000845	0.00603	CcSEcCtD
Cilostazol—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000843	0.00602	CcSEcCtD
Cilostazol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.00597	CcSEcCtD
Cilostazol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.00586	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000785	0.0056	CcSEcCtD
Cilostazol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.00556	CcSEcCtD
Cilostazol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000773	0.00552	CcSEcCtD
Cilostazol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000768	0.00548	CcSEcCtD
Cilostazol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00541	CcSEcCtD
Cilostazol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000749	0.00534	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00531	CcSEcCtD
Cilostazol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00526	CcSEcCtD
Cilostazol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00071	0.00506	CcSEcCtD
Cilostazol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.00503	CcSEcCtD
Cilostazol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000684	0.00488	CcSEcCtD
Cilostazol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00486	CcSEcCtD
Cilostazol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00486	CcSEcCtD
Cilostazol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000618	0.00441	CcSEcCtD
Cilostazol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.00435	CcSEcCtD
Cilostazol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000589	0.0042	CcSEcCtD
Cilostazol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00057	0.00406	CcSEcCtD
Cilostazol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000548	0.00391	CcSEcCtD
Cilostazol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000543	0.00387	CcSEcCtD
Cilostazol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000543	0.00387	CcSEcCtD
Cilostazol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.00385	CcSEcCtD
Cilostazol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000512	0.00365	CcSEcCtD
